This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Events, news, and information for the people who influence the business strategies of the life science industry.

MediSieve's CEO explains magnetic blood filtration at Xcelerate Startup Pitch Competition

Share this article

George Frodsham, CEO at MediSieve, won first runner up for Best Business Plan at the Xcelerate Startup Pitch Competition hosted by EBD Group and Xcelerate Insight during Biotech Week Boston in September, 2018. With the ability to specifically and selectively remove disease-causing agents from the blood, MediSieve’s magnetic blood filtration has the potential to transform the treatment of blood borne diseases such as sepsis, leukemia and malaria. The pitch competition is designed to give early stage companies exposure to possible investors and partners, and is judged by top venture capitalists and industry experts.

Share this article

Sign up for Partnering, Business Development & Licensing email updates

Upcoming event


06 - 08 Nov 2023, Munich, Germany


Go to site